Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Schering-Plough isolates potential lead for new schizophrenia drugs from Chinese plant

June 24, 1997

Lilly licenses Prozac patent rights from Interneuron for PMS treatment

June 24, 1997

MS&D describes potent and selective 5-HT1Dalpha receptor agonists

June 24, 1997

Agents for depression and related disorders from American Home Products

June 24, 1997

Melatonin reduces the effects of nifedipine in hypertensive patients

June 23, 1997

Gabitril introduced in Germany

June 23, 1997

IND filed for new anxiolytic compound, NGD-91-2

June 23, 1997

Monoamine reuptake inhibitors disclosed by NeuroSearch

June 23, 1997

Hi-Tech Pharmacal obtains license to huperzine

June 20, 1997

Preclinical results reported by Lilly and Synaptic for potent and selective 5-HT1F agonist

June 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...